Skip to content

Comparing Visual Function Tests in Glaucoma

Comparison of Visual Function Tests Across Glaucoma Stages - Visual Function Tests in Glaucoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58230
Enrollment
105
Registered
2025-04-29
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-angle glaucoma glaucoma, eye pressure disease, green eye disease

Interventions

Rapid Campimetry (RC):&nbsp
RC is a novel, kinetically based (with moving stimuli as opposed to stimuli at fixed test locations) perimetric technique that tests the central 30 degrees of the VF for areas of absolute functional l
SPP focuses on functional assessment in end-stage glaucoma by incorporating test points in the peripheral field, an area overlooked by SAP, which only probes the central 30 degrees of the VF. These pe
FST uses flashes of light to estimate the visual threshold of the entire retina simultaneously. Although it does not provide location-specific VF information, FST is particularly useful for patients w
Goldmann perimetry is the predecessor of the currently widespread SAP, where suprathreshold kinetic stimuli are moved gradually from outside the visual field towards the centre and the boundaries of t

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age: 18-80 yearsBeing able to understand the testsGlaucoma according to European glaucoma definitions and classificationsGlaucomatous retinal damage

Exclusion criteria

Exclusion criteria: Any known ophthalmic or neurological disease that might affect visual field, except for glaucomaAny previous eye operation except for uneventful cataract surgery and glaucoma surgeryillness or medical treatment that is incompatible with participation in the study

Design outcomes

Primary

MeasureTime frame
For each test, the test score will be normalised on a 0 (blind) to 100% (normal vision) scale and a response curve (mean test score as a function of disease stage) will be made. The main endpoint of the study is the X50 point (the point along the response curve with a mean test score of 50%) and the slope of the response curves (defined as as the rate of change in test score per unit increase in disease severity at the X50 point) of the five alternative techniques.

Secondary

MeasureTime frame
-

Countries

Netherlands

Contacts

Public ContactN.S Shafiabadi

Universitair Medisch Centrum Groningen

n.shafieabadi@umcg.nl0652903731

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 29, 2026